Hungary Pharmaceuticals & Healthcare Report Q3 2012 - New Market Research Report
BMI View: As BMI warned it would back in February, the Hungarian government has announced deeper cuts to its pharmaceutical budget for this year and next. Our markedly pessimistic and contractionary outlook for the Hungarian pharmaceutical market, which we have had for well over a year, has been reinforced by the latest version of the structural reform package Szell Kalman Plan 2.0. We have adjusted our forecasts down further, reflecting the changes to budget, though based on the National Healthcare...
View full press release